BSE Live
Apr 02, 16:01Prev. Close
156.35
Open Price
155.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Makers Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -0.25 | 4.98 | 6.22 | 7.52 | 4.69 | |
| Diluted EPS (Rs.) | -0.25 | 4.98 | 6.22 | 7.52 | 4.69 | |
| Cash EPS (Rs.) | 3.79 | 8.04 | 9.41 | 9.72 | 7.23 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 90.74 | 84.81 | 74.89 | 69.28 | 53.57 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 90.74 | 84.81 | 74.89 | 69.28 | 53.57 | |
| Dividend / Share(Rs.) | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Revenue from Operations/Share (Rs.) | 104.53 | 94.82 | 113.78 | 118.23 | 124.89 | |
| PBDIT/Share (Rs.) | 5.98 | 9.71 | 12.54 | 12.00 | 10.32 | |
| PBIT/Share (Rs.) | 1.94 | 6.65 | 9.34 | 9.81 | 7.78 | |
| PBT/Share (Rs.) | 0.51 | 6.13 | 8.61 | 10.85 | 7.13 | |
| Net Profit/Share (Rs.) | -0.25 | 4.98 | 6.22 | 7.52 | 4.69 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 5.71 | 10.23 | 11.01 | 10.15 | 8.26 | |
| PBIT Margin (%) | 1.85 | 7.01 | 8.21 | 8.29 | 6.22 | |
| PBT Margin (%) | 0.48 | 6.46 | 7.57 | 9.17 | 5.70 | |
| Net Profit Margin (%) | -0.24 | 5.25 | 5.46 | 6.36 | 3.75 | |
| Return on Networth / Equity (%) | -0.27 | 5.87 | 8.30 | 10.86 | 8.75 | |
| Return on Capital Employed (%) | 1.74 | 6.71 | 12.16 | 10.54 | 7.50 | |
| Return on Assets (%) | -0.16 | 4.08 | 5.73 | 7.36 | 5.73 | |
| Total Debt/Equity (X) | 0.19 | 0.14 | 0.04 | 0.04 | 0.01 | |
| Asset Turnover Ratio (%) | 69.57 | 77.69 | 104.97 | 115.79 | 152.72 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.23 | 2.02 | 1.78 | 1.65 | 2.39 | |
| Quick Ratio (X) | 0.68 | 0.99 | 0.92 | 1.13 | 1.74 | |
| Inventory Turnover Ratio (X) | 4.81 | 4.00 | 4.19 | 7.27 | 10.06 | |
| Dividend Payout Ratio (NP) (%) | -397.17 | 20.07 | 16.08 | 13.29 | 21.32 | |
| Dividend Payout Ratio (CP) (%) | 26.38 | 12.44 | 10.62 | 10.29 | 13.82 | |
| Earnings Retention Ratio (%) | 497.17 | 79.93 | 83.92 | 86.71 | 78.68 | |
| Cash Earnings Retention Ratio (%) | 73.62 | 87.56 | 89.38 | 89.71 | 86.18 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 22.20 | 29.62 | 37.05 | 46.59 | 28.69 | |
| EV/Net Operating Revenue (X) | 0.43 | 0.64 | 0.66 | 0.80 | 0.47 | |
| EV/EBITDA (X) | 7.55 | 6.21 | 6.01 | 7.89 | 5.66 | |
| MarketCap/Net Operating Revenue (X) | 0.29 | 0.56 | 0.64 | 0.85 | 0.48 | |
| Retention Ratios (%) | 497.17 | 79.92 | 83.91 | 86.70 | 78.67 | |
| Price/BV (X) | 0.33 | 0.62 | 0.98 | 1.45 | 1.13 | |
| Price/Net Operating Revenue | 0.29 | 0.56 | 0.64 | 0.85 | 0.48 | |
| Earnings Yield | -0.01 | 0.09 | 0.08 | 0.07 | 0.08 |
20.02.2026
Makers Labs Consolidated December 2025 Net Sales at Rs 35.67 crore, up 28.81% Y-o-Y
19.02.2026
Makers Labs Standalone December 2025 Net Sales at Rs 12.70 crore, up 34.43% Y-o-Y
14.11.2025
Makers Labs Consolidated September 2025 Net Sales at Rs 34.17 crore, up 15.58% Y-o-Y
12.11.2025
Makers Labs Standalone September 2025 Net Sales at Rs 12.64 crore, up 9.89% Y-o-Y
20.02.2026
Makers Labs Consolidated December 2025 Net Sales at Rs 35.67 crore, up 28.81% Y-o-Y
19.02.2026
Makers Labs Standalone December 2025 Net Sales at Rs 12.70 crore, up 34.43% Y-o-Y
14.11.2025
Makers Labs Consolidated September 2025 Net Sales at Rs 34.17 crore, up 15.58% Y-o-Y
12.11.2025
Makers Labs Standalone September 2025 Net Sales at Rs 12.64 crore, up 9.89% Y-o-Y
02.04.2026
02.04.2026
Lupin shares down 2% as arm to acquire 43.38% stake in Multicare Pharma
02.04.2026
02.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth